HSCS AND HIF · The role of hypoxia-inducible factors in human haematopoietic stem cell biology and leukaemogenesis
7РП — „Хора“ (Действия „Мария Кюри“)
- Период
- 2010-07-01 → 2013-01-08
- Финансиране от ЕС
- 172 741 €
- Участници
- 1
- Схема
- MC-IEF
Линиите свързват координатора с партньорите.
Накратко на български
Хемопоетичните стволови клетки и техните протеини (HIF), които реагират на нивата на кислород, се анализират чрез блокиране на конкретни гени. Това помага да се разбере как се поддържат тези клетки и как се развива левкемията.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
The role of hypoxia-inducible factors in human haematopoietic stem cell biology and leukaemogenesis
Hematopoietic stem/progenitor cells (HSPCs), which reside in bone marrow niches, are exposed to low levels of oxygen and follow an oxygen gradient throughout their differentiation. Hypoxia-inducible factors (HIFs) are the main factors regulating the cell response to oxygen variation. However the role of HIF-1a and HIF-2a in human HSPCs is still unclear. During the period of my Marie Curie grant I have studied the role of HIF factors in normal hematopoiesis and leukemia development. These are the results obtained: 1. We have shown for the first time that HIF-1a and HIF-2a subunits are expressed in freshly isolated HSPCs cord blood-derived cells. 2. To investigate the role of each of the HIF-a subunits we constructed lentiviral vectors containing small hairpin RNA (shRNA) against HIF-1a and HIF-2a subunits. We have confirmed the efficient knock down both at the mRNA and protein levels. 3. We have shown that silencing HIF-2a and to a lesser extent HIF-1a affects human short-term repopulating cells in vivo using the NSG (NOD-SCID/IL2Rgnull) xenotransplantation model. We have observed that the defect in the engraftment is not due to a homing defect. 4. To address the impact that each of the HIF-a subunits could have in the self-renewal capacity of human long-term HSPCs we have performed secondary transplantations. We have shown that knockdown (KD) of HIF-2a but not HIF-1a impairs the long-term reconstitution ability of human HSCs, demonstrating that the maintenance of human HSCs with self-renewing ability is dependent on HIF-2a. 5. To better understand the role of HIF-a in HSPCs, we knocked-down the binding partner of the HIF-a subunits, the constitutively expressed beta subunit (HIF-1beta). We have demonstrated that HIF-1beta KD in HSPCs recapitulates the HIF-2a KD phenotype, confirming the role of HIF complexes in the maintenance of human HSPCs. 6. To better understand the molecular mechanisms by which HIF-2a regulates HSPC biology, we have performed a large-scale gene expression analysis in KD cells compared to control. Gene pathway enrichment analysis identified the oxidative stress, endoplasmic reticulum (ER) stress response and apoptosis pathways as those with the largest change in gene signature. We have validated this and demonstrated that: • HIF-2a KD increases ROS production and affects mitochondria homeostasis. • The increase in ROS production in HIF2a KD cells induces the Endoplasmic Reticulum (ER) stress and triggers the Unfolded Protein Response (UPR) signalling pathway. • Treatment with tunicamycin (TM), a well-known inducer of the UPR pathway, increases the percentage of apoptotic cells in shHIF2a cells compared to shCtl. This suggests that HIF-2a silenced HSPCs have significantly increased levels of ER stress and are more susceptible to apoptosis as a result. • Finally we rescue the apoptosis caused by TM by pre-treating the cells with either NAC or tempol, two potent antioxidants, as significantly fewer apoptotic cells are observed. 7. In solid tumors, the expression of HIF-2a has been associated with poor prognosis and we therefore decided to investigate the effect of the KD of HIF-2a on human primary Acute Myeloid Leukemia (AML). We have observed that HIF-2a KD impedes the growth of human AML, both in vitro and in vivo. In addition, HIF-2a KD cells are more susceptible to apoptosis as a result of ER stress. Conclussions In this work, we examine the effect of the knockdown (KD) of HIF-1a and HIF-2a in human HSPCs. We observe that silencing HIF-2a, and to a lesser degree HIF-1a, impedes the repopulating capacity of HSPC-derived umbilical cord blood (UCB) in vivo. We demonstrate that HIF-2a KD HSPCs show signs of endoplasmic reticulum (ER) stress and activate the unfolded protein response (UPR) pathway, which ultimately affects the survival of the HSPCs. Moreover, we observe that the increase in the ER stress response in HIF-2a KD cells is due to an increase in reactive oxygen species (ROS) production. We also describe that cells from AML patient samples are dependent on the level of HIF-2a for their survival. Collectively, our report provides further evidence of a central role for HIF-2a in protecting HSPCs and AML cells from apoptosis induced by ER stress. Socio-economic impact Defining the role of HIF in HSPCs provides for the first time a molecular link between the hypoxic niche and quiescent HSPCs and helps to understand how HSPCs are maintained in their niches. Nowadays it is starting to be accepted that leukemic stem cells (LSCs) contribute to tumor progression through preferential resistance to radiation and chemotherapy. Therefore the elucidation of new molecular regulators essential for the normal stem cell biology that might be deregulated in LSCs is crucial for the development of anti-cancer therapies
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Mammalian haematopoiesis in the adult takes place predominantly in the bone marrow (BM) where a population of haematopoietic stem cells (HSC) are located. HSC are able to self-renew and give rise to all the blood cell types. The fate choice of HSC to either self-renew or differentiate is controlled by an interplay between intrinsic mechanisms and extrinsic signals from the surrounding environment called stem cell niche. The existence of a hypoxic niche in the BM has been highlighted in the last decade. It has been proposed that the most quiescent HSC reside in the most hypoxic areas in the BM suggesting that low oxygen levels might play a key role in the maintenance of HSC. However the molecular mechanisms by which HSC respond to hypoxia have not been elucidated. Cells have developed a molecular mechanism for oxygen sensing. An important mediator is the transcriptional complex hypoxia-inducible factor (HIF). At low oxygen levels, HIF is stabilized and regulates the transcription of crucial genes involved in cell proliferation, survival and differentiation. Under normoxia, HIF has a low transcriptional activity. In addition, HIF has been reported to be upregulated in certain pathological conditions such as cancer where a high expression of HIF correlates with a poor prognosis. The aim of this project is to understand the molecular mechanisms by which human HSC response to their hypoxic environment. I will address this question by studying the role of HIF in HSC. I will first concentrate on analysing the consequences that genetically manipulating HIF might have on HSC in vitro and in vivo. Secondly I will analyse whether HIF is upregulated in leukemic stem cells (LSC) and in such a case, I will finally investigate the consequences that downregulating HIF might have in the modulation of leukaemia. Defining the role of HIF in HSC and LSC will provide for the first time a molecular link between the hypoxic niche, HSC maintenance and leukaemia development in humans.
Оригинален текст от CORDIS (на английски).
Участници
- CANCER RESEARCH UK LBG · LONDONКоординаторОбединеното кралство
Връзки
Данни: CORDIS, © Европейски съюз
